NACFC 2022 | W16: Updates in Cystic Fibrosis Pharmacotherapy

This session will focus on cystic fibrosis pharmacotherapy issues facing practitioners today. The topics discussed include clinical outcomes of real-world CFTR modulator use in the CF population, medication toxicities, and models of pharmacy integration within the CF care team. This session reviews the changing landscape in clinical care of patients taking CFTR modulators.
Orginally recorded November 4, 2022.